·JournalofShaoguanUniversity·NaturalScience20109319Sep.2010Vol.31No.9,,,(,512005):,.:;;:Q932:A:1007-5348(2010)09-0077-03:2010-07-28:(2009314-140546):(1955-),,,,.(Batrerialbiofilm,BF).,、、、.,.17(AntonievenLeeuwenhoek),,,,,200.2070Characklis,[1].,,,()().,,,,、、.,,.,,.1(),、、(1999BF).,,.:,,BF、、、、、、.,,,.,,,,·2010,,10.10~20.1996,,,70[2].,,,、、、,,、,.,,,.,2mm,,,,,,,,,,,.,,,,,,,,.、,,.21978,BillCosterton.Bill,.(biofilm).,.Bill.Bill(centerofbiofilmengineering),.,,、、、、,.,65%[3].,,.,、[4]..,,[5],.,,.,92%~93%;33.3%;99%;,,[3].,,、.,、、、、.,、、、、、、、[6],,,,.1995,,,78··9,,.“”,,.,[1].,,,.,BF“”,.60.,,,.,.,,..BF,BF,50[7,8]....3,.,,,,,,,,,.:[1]CostertonJW,StewartPS.Battlingbiofilms[J].SciAm,2001,285(1):74-81.[2]BauerTr,TorresA,FerrerR,etal.Biofilmformationinendotrachealtubes:Associationbetweenpneumoniaandthepersistenceofpathogents[J].MonaldiArchChestDis,2002,57(1):84-87.[3]ChicurelM.Bacterialbiofilmsandinfecions-xlimebusters[J].Nature,2000,408(4):284.[4]DeRykeCA,LeeSY,KutiJL,etal.Optimisingdosingstrategiesofantibacteralsutilisingpharmacody-namicprinciples:impactonthedevelopmentofresistance[J].Drugs,2006,66(1):1-3.[5].[J].,1999,15(2):299-307.[6]MoskowitzSM,FosterJM,EmersonJ,etal.ClinicallyfeasiblebiofilmsusceptibilityassayforisolatesofPseudomonasaeruginosefrompatientswithcysticfibrosis[J]..JClinicMicrobiol,2004,42:1915.[7]PalZ,UrbanE,DoseE,etal.Biofilmformationonintrauterinedevicesinrelationtodurationofnse[J].JMedMicrobiol,2005,54(12):1199-1203.NaturalattributesandpathogenicityofbacterialbiofilmHUANGXiao-min,ZHENGQiu-hua,GUANGWeng-hua,LINShao-yun(YingdongCollegeofLifeScience,ShaoguanUniversity,Shaoguan512005,Guangdong,China)Abstract:Thebacterialbiofilmisrelativelysinglescatteredinthefreestateofbacteriainanotherformofexistence,itsuniquecharacteristicoftheclusterphenotypedecidestheadaptabilityofhumanbodybacteriumgroupandnaturalenvironmentwidely.Keywords:bacterialbiofilm(BF);resistance;pathogenic(ED.:S,Z),:79··